
The oral antiviral CD04872SC demonstrates promise in neutralizing COVID-19 variants, indicating the possibility of broad-spectrum treatment.
Researchers from the University of Houston College of Pharmacy discuss their discovery of a small molecule drug candidate that could provide immediate protection against infection with the severe acute respiratory …
The oral antiviral CD04872SC demonstrates promise in neutralizing COVID-19 variants, indicating the possibility of broad-spectrum treatment. Read More